News

Javelin’s new patent will cover the major European Union market countries (G5) as well as an additional 20 member states of the European patent convention. This new patent

In this single-blinded study in Type 2 diabetic subjects Akesis dosed a total of 10 Type 2 diabetic patients with either 20mg of AKP-020 or placebo. While Akesis

Sales of the Pronto V3 catheter in Japan are expected to commence in the third quarter of 2008. The Pronto V3 catheter is designed for the mechanical aspiration

In Living Cell Technologies’s (LCT) first Phase I/IIa trial of DiabeCell, its lead product of encapsulated porcine insulin producing cells, five patients have been implanted with the lowest

In accordance with the agreement, teams of ChemDiv and Schering Plough scientists will work closely to develop exclusive small molecule libraries enhancing Schering Plough’s global drug discovery effort.

Under the terms of this National Institutes of Health small business innovative research grant award, Chembio will receive approximately 2/3 of the grant funds, or approximately $200,000, with

According to Medtronic, its Talent thoracic stent graft system makes thoracic endovascular aortic repair accessible to an additional 25% of patients, because of its unique features. It is

In preclinical studies, Achillion has demonstrated that ACH-1625 has an excellent safety profile and a pharmacokinetic profile characterized by rapid and extensive partitioning to the liver. ACH-1625 has

The primary objective of the Phase I clinical trial is to assess safety and tolerability of an oral dose of SP-304 in healthy adult volunteers. SP-304 is an